This article is more than 5 years old. Information may no longer be current.

FDA approves study for Implantable Miniature Telescope in post-cataract patients

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The FDA has approved a clinical study of the Implantable Miniature Telescope in patients with age-related macular degeneration who were previously implanted with an IOL, according to a VisionCare press release.

The implant, already FDA approved for AMD patients older than 65 years who have not had cataract surgery, is currently contraindicated for patients who have had previous corneal or intraocular surgeries, the release said. In the trial, patients’ existing IOLs will be replaced with the miniature telescope to study its safety and effectiveness.

The study will be conducted at selected U.S. CentraSight providers, which are currently seeking patients to participate.